Page 42 - 2021 Taiwan Food and Drug Administration Annual Report
P. 42
entry of counterfeit drugs into the legitimate 2FWREHU
VXSSO\ FKDLQ $W WKH VDPH WLPH LW FRQWLQXHV (II) To assist pharmaceutical companies to
to enhance and expand the functions of the
online submission system for drug registra- GHFODUH WKH WUDFH DQG WUDFN GDWD 7)'$ KDV
WLRQ DFFHOHUDWH RSHUDWLRQV DQG LPSURYH GH- not only established consultation hotlines
OLYHU\ TXDOLW\ DQG DFWLYHO\ VWUHQJWKHQ DFWLYH DQG PXOWLSOH ZD\V RI GHFODULQJ DQG DOVR
and passive drug monitoring practices for continued organizing training courses and
better risk management and control. educational publicity.
,,, ,Q WKH VWDWLVWLFDO DQDO\VLV DQG
Implementation Strategy early warning functions of ephedrine/
pseudoephedrine preparations were
I. Improved Taiwan’s electronic added to the system to enable the health
submission system authorities to inquire data immediately.
,Q RUGHU WR LPSURYH WKH H൶FLHQF\ RI WKH III. Reinforced the drug safety
FRXQWU\¶V GUXJ LQVSHFWLRQ GUXJ DGPLQLVWUD- surveillance and analysis
WLRQ DQG GUXJ UHYLHZ RSHUDWLRQV DQG FRP-
ply with the regulations of the International TFDA continues to monitor and analyze
Council for Harmonisation of Technical Re- drug safety through the post-market adverse
quirements for Pharmaceuticals for Human GUXJ UHDFWLRQ UHSRUWLQJ V\VWHP GRPHVWLF DQG
8VH ,&+ DQG RWKHU LQWHUQDWLRQDO VWDQGDUGV IRUHLJQ GUXJV VDIHW\ LQIRUPDWLRQ PRQLWRULQJ
TFDA continues to develop relevant elec- and national drug safety related database.
tronic common technical document guidance ,Q DGGLWLRQ LQ RUGHU WR VWUHQJWKHQ WKH
and system function enhancements and the practicability and convenience of the adverse
digital integration of the electronic review GUXJ UHDFWLRQ UHSRUWLQJ V\VWHP WKH ,&+
WDVN IXUWKHU LPSURYLQJ WKH GUXJ UHJLVWUDWLRQ ( % 5 DGYHUVH GUXJ UHDFWLRQ QRWL¿FDWLRQ
system was formally implemented starting
II. Improvement of the trace and on September 2020.
track system of drugs
$FKLHYHPHQWV DQG %HQH¿WV
(I) TFDA continues selecting drugs to be
included in “Trace and Track System I. Reinforced the digitalization
IRU 0HGLFLQDO 3URGXFWV ´ 7)'$ KDV management of Taiwan’s drug
LQFOXGHG EORRG SUHSDUDWLRQV YDFFLQHV administration
DQG ERWXOLQXP WR[LQ SUHSDUDWLRQV KLJK
concerned 50 items that are more likely By integrating medical regulations and
WR EH FRXQWHUIHLWHG SVHXGRHSKHGULQH LQIRUPDWLRQ PDQDJHPHQW 7)'$ KDV DGRSWHG
DQG HSKHGULQH SUHSDUDWLRQV $GGLWLRQDOO\ a full online application approach for some
Medicinal nitrous oxide was included on application types starting July 2020. The
Guidance on Taiwan Electronic Common
40
